Trade Summary

1 week ago, Frost Phillip Md Et Al, serving as Dir, 10% owner at Cocrystal Pharma, Inc. (COCP), purchased 65,000 shares at $0.97 per share, for a total transaction value of $63,202.00. Following this transaction, Frost Phillip Md Et Al now holds 1,795,651 shares of COCP.

This purchase represents a 4.00% increase in Frost Phillip Md Et Al's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, December 24, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 5 days after the trade was made.

Cocrystal Pharma, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.